Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Motor Activity 8Breast Neoplasms 4Prostatic Neoplasms 3Neoplasms 2Colonic Neoplasms 2Vomiting 1Sedentary Behavior 1Rectal Neoplasms 1Prostatectomy 1Obesity 1Nausea 1Lymphedema 1Lung Neoplasms 1Leukemia 1Gastric Adenocarcinoma 1Fatigue 1Cardiometabolic Dysregulation 1Brain Neoplasms 1Atherosclerosis 1

Interventions

Ondansetron 3Aprepitant 3casopitant 1Vincristine 1Tropisetron 1Therapeutics 1Rituximab 1R-CHOP protocol 1Psychiatric Rehabilitation 1Prochlorperazine 1Prednisolone 1Palonosetron 1Midazolam 1Metoclopramide 1Lorazepam 1Granisetron 1Exercise 1Doxorubicin 1Dexmedetomidine 1Dexamethasone 1Cyclophosphamide 1Antiemetics 1Acupuncture Points 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Nausea × Exercise × Clear all
NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

GlaxoSmithKline

Phase 3 Withdrawn
Thoracic

Lung Neoplasms, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡